Plks as Novel Targets for Cancer Drug Design

Checkpoint Responses in Cancer Therapy - Cancer Drug Discovery and Development• ◽

10.1007/978-1-59745-274-8_12 ◽

2008 ◽

pp. 271-290

Author(s):

Wei Dai ◽

Yali Yang ◽

Ning Jiang

Keyword(s):

Drug Design ◽

Cancer Drug ◽

Download Full-text

Editorial (Hot Topic: Cross-Talking Metabolism and Epigenetics in Anti-Cancer Drug Design)

Current Pharmaceutical Design ◽

10.2174/1381612811306040529 ◽

2012 ◽

Vol 19 (4) ◽

pp. 529-531

Author(s):

Alberto Del Rio

Keyword(s):

Drug Design ◽

Cancer Drug ◽

Download Full-text

Structure of human cortisol-producing cytochrome P450 11B1 bound to the breast cancer drug fadrozole provides insights for drug design

Journal of Biological Chemistry ◽

10.1074/jbc.ra118.006214 ◽

2018 ◽

Vol 294 (2) ◽

pp. 453-460 ◽

Author(s):

Simone Brixius-Anderko ◽

Emily E. Scott

Keyword(s):

Breast Cancer ◽

Cytochrome P450 ◽

Drug Design ◽

Download Full-text

Computational Methods for the Analysis and Prediction of EGFR-mutated Lung Cancer Drug Resistance: Recent Advances in Drug Design, Challenges and Future Prospects

IEEE/ACM Transactions on Computational Biology and Bioinformatics ◽

10.1109/tcbb.2022.3141697 ◽

2022 ◽

pp. 1-1

Author(s):

Rizwan Qureshi ◽

Bin Zou ◽

Tanvir Alam ◽

Jia Wu ◽

Victor Lee ◽

...

Keyword(s):

Lung Cancer ◽

Drug Resistance ◽

Drug Design ◽

Computational Methods ◽

Cancer Drug ◽

Future Prospects ◽

Cancer Drug Resistance ◽

Recent Advances ◽

Egfr Mutated ◽

Design Challenges

Download Full-text

Anti-cancer Drug Design

Archives of Clinical Microbiology ◽

10.4172/1989-8436-c3-011 ◽

2018 ◽

Vol 09 ◽

Author(s):

M SISSAOUI

Keyword(s):

Drug Design ◽

Cancer Drug ◽

Download Full-text

EDITORIAL Oncology Research Incorporating Anti-Cancer Drug Design

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ◽

10.3727/096504002108747890 ◽

2002 ◽

Vol 13 (1) ◽

pp. 1-1

Author(s):

S. Neidle ◽

A.C. Sartorelli

Keyword(s):

Drug Design ◽

Cancer Drug ◽

Oncology Research ◽

Download Full-text

Proteomics for cancer drug design

Expert Review of Proteomics ◽

10.1080/14789450.2019.1650025 ◽

2019 ◽

Vol 16 (8) ◽

pp. 647-664 ◽

Author(s):

Amanda Haymond ◽

Justin B. Davis ◽

Virginia Espina

Keyword(s):

Drug Design ◽

Download Full-text

Investigating core genetic-and-epigenetic cell cycle networks for stemness and carcinogenic mechanisms, and cancer drug design using big database mining and genome-wide next-generation sequencing data

10.1080/15384101.2016.1198862 ◽

2016 ◽

Vol 15 (19) ◽

pp. 2593-2607 ◽

Author(s):

Cheng-Wei Li ◽

Bor-Sen Chen

Keyword(s):

Next Generation Sequencing ◽

Drug Design ◽

Next Generation Sequencing Data ◽

Cancer Drug ◽

Database Mining ◽

Next Generation ◽

Sequencing Data ◽

Genome Wide ◽

Generation Sequencing

Download Full-text

SH2 and SH3 domains: Potential targets for anti-cancer drug design

Journal of Pharmacological and Toxicological Methods ◽

10.1016/1056-8719(95)00082-7 ◽

1995 ◽

Vol 34 (3) ◽

pp. 125-132 ◽

Author(s):

Thomas E. Smithgall

Keyword(s):

Drug Design ◽

Cancer Drug ◽

Sh3 Domains ◽

Download Full-text

Modifications to the dNTP triphosphate moiety: From mechanistic probes for DNA polymerases to antiviral and anti-cancer drug design

Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics ◽

10.1016/j.bbapap.2010.01.005 ◽

2010 ◽

Vol 1804 (5) ◽

pp. 1223-1230 ◽

Author(s):

Charles E. McKenna ◽

Boris A. Kashemirov ◽

Larryn W. Peterson ◽

Myron F. Goodman

Keyword(s):

Drug Design ◽

Dna Polymerases ◽

Cancer Drug ◽

Download Full-text

Casein Kinase II: An attractive target for anti-cancer drug design

The International Journal of Biochemistry & Cell Biology ◽

10.1016/j.biocel.2010.06.010 ◽

2010 ◽

Vol 42 (10) ◽

pp. 1602-1605 ◽

Author(s):

Ismail Muhamad Hanif ◽

Ibrahim Muhammad Hanif ◽

Muhammad Ali Shazib ◽

Kashif Adil Ahmad ◽

Shazib Pervaiz

Keyword(s):

Drug Design ◽

Casein Kinase Ii ◽

Casein Kinase ◽

Cancer Drug ◽

Download Full-text